Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Pilot phase II study of the combination of lenvatinib (L) and eribulin (E) in advanced solid tumors.
Pilot phase II study of the combination of lenvatinib (L) and eribulin (E) in advanced solid tumors.
Journal: International journal of cancer
Published: September 17, 2024
Editor's Note: Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom Macroglobulinemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 16, 2024
Prevalence of hepatopancreatic injury and clinical outcomes in patients with COVID-19 in USA.
Journal: International journal of emergency medicine
Published: July 29, 2021
Renin-Angiotensin-Aldosterone System Blockers Prior to Hospitalization and Their Association With Clinical Outcomes in Coronavirus Disease 2019 (COVID-19).
Journal: Cureus
Published: March 24, 2021
Phase I/II trial of everolimus in combination with bortezomib and rituximab (RVR) in relapsed/refractory Waldenstrom macroglobulinemia.
Journal: Leukemia
Published: March 30, 2015
Extramedullary Waldenström macroglobulinemia.
Journal: American journal of hematology
Published: July 15, 2014
Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenström macroglobulinemia.
Journal: Blood
Published: January 05, 2013
Mechanisms of activity of the TORC1 inhibitor everolimus in Waldenstrom macroglobulinemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 11, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026